Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Running, not enrolling · Phase 2

Conditions studied: Myasthenia Gravis, Generalized

In brief

This is a Phase IIb study to evaluate the safety and preliminary efficacy of Descartes-08 CAR T-cells in patients with Generalized Myasthenia Gravis

Key facts

Study ID
NCT04146051
Run by
Cartesian Therapeutics
People needed
30
Starts
2019-12-04
Expected to finish
2026-03-31
Last updated by the study team
2025-05-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.